Objective: The study aimed to describe the current epidemiological, clinical and immunological profile of newly
detected HIV - positive patients in Northern Benin by 2016. Methods: It was a prospective study conducted from May 2 to
October 31, 2016 on three main sites of care of people living with... HIV (PLHIV) in the department of Borgou in Benin. All
new cases of HIV infection have been systematically and comprehensively recruited. Initial epidemiological, clinical and
immunological data were collected using a questionnaire. These data were entered and analyzed using the Epi Info 7 software.
Results: In total, 185 adults (68 male and 117 female) newly screened HIV positive were included in this study. The middle age
was 36.2 ± 10.9 years and the sex ratio was 0.6 One hundred and thirty-five patients (73%) were between 25 and 50 years old.
In terms of the profession, 132 patients (71.3%) were engaged in liberal activities (craftmen, traders and retailers). The
majority was schooled (113 or 61.1%) and resided in urban areas (146 or 79%). One hundred and sixteen patients lived in
couple (62.7%) with an average monthly income estimated at 70 US Dollars. Clinically, 123 patients (66.5%) were in WHO
stage III. The body mass index was over 18.5 kg/m2 in 124 patients (67%). The median number of TCD4 lymphocytes was
254.5 cells/ml and 25 patients (13.5%) had a number of CD4 over 500 cells/ml. HIV1 was really predominant (97.8%). Most
patients (152 or 82.2%) had been screened for clinical suspicion. Conclusion: HIV infection in Benin remains the prerogative
of young, female, educated and poor people. Screening is delayed and hence the need to develop innovative strategies for early
more
Report
A Project of the Joep Lange Institute July, 2018
En 2016, l’ONUSIDA lançait un appel pour que les pays d’Afrique de l’Ouest et du Centre accélérent la riposte au sida. En effet, si dans des pays d’Afrique de l’Est et du Sud les avancées sont réelles, ceux de l’Afrique de l’Ouest et du Centre sont encore en retard dans l’accès... au dépistage et au traitement antirétroviral. Le 3 juillet 2017, les Présidents de l’Union Africaine avaient adopté un plan de rattrapage pour l’Afrique de l’Ouest et du Centre avec l’appui de ONUSIDA, dans le but d’inverser la tendance de l’épidémie et combler les gaps financiers et programmatiques pour l’atteinte des 90-90-90 en 2020. Le Sénégal, à l’instar des pays de la sous région, s’est engagé à élaborer et mettre en œuvre son plan de rattrapage en 2018 pour accélérer les interventions vers l’atteinte de cet objectif. Le plan de rattrapage du Sénégal est lancé officiellement en janvier 2018 au Novotel en présence des autorités, des acteurs et des partenaires.
more
Supplement Article
J Acquir Immune Defic Syndr Volume 75, Supplement 2, June 1, 2017 Building Health Systems through Implementation Research
Published by Wolters Kluwer Health, Inc.
Compendium of Case Studies